Variant report

Variant	nsv1060280
Chromosome Location	chr19:43866823-43959685
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1404)
CpG islands
(count:1404)
Chromatin interactive
region (count:33)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1404 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:43936967-43937303	K562	blood:	n/a	n/a
2	ARID3A	chr19:43948815-43949085	K562	blood:	n/a	n/a
3	ARID3A	chr19:43951186-43951527	K562	blood:	n/a	n/a
4	BACH1	chr19:43937068-43937435	K562	blood:	n/a	n/a
5	BACH1	chr19:43951148-43951411	K562	blood:	n/a	n/a
6	BCL3	chr19:43943124-43943602	A549	lung:	n/a	n/a
7	BCL3	chr19:43942854-43943565	A549	lung:	n/a	n/a
8	BHLHE40	chr19:43947828-43948038	K562	blood:	n/a	n/a
9	BHLHE40	chr19:43937017-43937430	K562	blood:	n/a	n/a
10	BHLHE40	chr19:43948832-43949262	K562	blood:	n/a	n/a
11	BHLHE40	chr19:43936863-43937386	GM12878	blood:	n/a	n/a
12	BHLHE40	chr19:43951076-43951587	K562	blood:	n/a	n/a
13	BHLHE40	chr19:43941474-43941725	K562	blood:	n/a	n/a
14	CBX3	chr19:43917535-43917884	K562	blood:	n/a	n/a
15	CBX3	chr19:43917630-43917850	K562	blood:	n/a	n/a
16	CCNT2	chr19:43948831-43949088	K562	blood:	n/a	n/a
17	CEBPB	chr19:43916687-43916887	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr19:43896514-43896714	K562	blood:	n/a	n/a
19	CEBPB	chr19:43896574-43896768	H1-hESC	embryonic stem cell:	n/a	n/a
20	CEBPB	chr19:43928885-43929232	HepG2	liver:	n/a	chr19:43929097-43929108
21	CEBPB	chr19:43896414-43896759	IMR90	lung:	n/a	n/a
22	CEBPB	chr19:43928890-43929216	A549	lung:	n/a	chr19:43929097-43929108
23	CEBPB	chr19:43926854-43927175	IMR90	lung:	n/a	chr19:43926999-43927010
24	CEBPB	chr19:43926918-43927173	A549	lung:	n/a	chr19:43926999-43927010
25	CEBPB	chr19:43931758-43932062	HepG2	liver:	n/a	chr19:43931836-43931847 chr19:43931836-43931847
26	CEBPB	chr19:43928882-43929119	IMR90	lung:	n/a	chr19:43929097-43929108
27	CEBPB	chr19:43876631-43876918	IMR90	lung:	n/a	n/a
28	CEBPB	chr19:43951333-43951649	K562	blood:	n/a	n/a
29	CEBPB	chr19:43951272-43951703	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr19:43926815-43927157	K562	blood:	n/a	chr19:43926999-43927010
31	CEBPB	chr19:43943332-43943525	A549	lung:	n/a	n/a
32	CEBPB	chr19:43933642-43933750	A549	lung:	n/a	n/a
33	CEBPB	chr19:43959484-43960149	MCF-7	breast:	n/a	n/a
34	CEBPB	chr19:43951315-43951649	IMR90	lung:	n/a	n/a
35	CEBPB	chr19:43920752-43920932	K562	blood:	n/a	n/a
36	CEBPB	chr19:43896505-43896663	HepG2	liver:	n/a	n/a
37	CEBPB	chr19:43928874-43929095	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr19:43942346-43943574	Hela-S3	cervix:	n/a	chr19:43943165-43943178 chr19:43943273-43943286
39	CEBPB	chr19:43948301-43949068	K562	blood:	n/a	n/a
40	CEBPB	chr19:43896450-43896720	A549	lung:	n/a	n/a
41	CEBPB	chr19:43926858-43927126	Hela-S3	cervix:	n/a	chr19:43926999-43927010
42	CEBPB	chr19:43933433-43933848	K562	blood:	n/a	n/a
43	CEBPB	chr19:43959511-43960196	MCF-7	breast:	n/a	n/a
44	CEBPB	chr19:43926853-43927151	HepG2	liver:	n/a	chr19:43926999-43927010
45	CEBPB	chr19:43928942-43929136	K562	blood:	n/a	chr19:43929097-43929108
46	CEBPD	chr19:43948671-43949170	K562	blood:	n/a	n/a
47	CHD1	chr19:43951004-43952036	IMR90	lung:	n/a	n/a
48	CHD2	chr19:43951103-43951495	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr19:43951158-43951472	K562	blood:	n/a	n/a
50	CTCF	chr19:43951300-43951450	MCF-7	breast:	n/a	chr19:43951353-43951366 chr19:43951350-43951368 chr19:43951351-43951367 chr19:43951353-43951366

(count:1404 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43922332-43922382	HIPEpiC	eye:	n/a
2	chr19:43922332-43922382	HIPEpiC	eye:	n/a
3	chr19:43891281-43891331	AG10803	skin:	n/a
4	chr19:43918408-43918458	SKMC	muscle:	n/a
5	chr19:43892826-43892876	HEEpiC	esophagus:	n/a
6	chr19:43891281-43891331	SKMC	muscle:	n/a
7	chr19:43922332-43922382	IMR90	lung:	fetal
8	chr19:43919003-43919053	Hepatocyte	liver:	n/a
9	chr19:43891866-43891916	NHBE	bronchial:	n/a
10	chr19:43918974-43919024	HRCEpiC	kidney:	n/a
11	chr19:43918408-43918458	BE2_C	brain:	n/a
12	chr19:43892826-43892876	IMR90	lung:	fetal
13	chr19:43912227-43912277	HL-60	blood:	n/a
14	chr19:43918943-43918993	NHDF-neo	bronchial:	n/a
15	chr19:43918974-43919024	GM19239	blood:	n/a
16	chr19:43919028-43919078	K562	blood:	n/a
17	chr19:43919003-43919053	AG10803	skin:	n/a
18	chr19:43919028-43919078	MCF-7	breast:	n/a
19	chr19:43912492-43912542	AG04449	skin:	fetal
20	chr19:43918408-43918458	AG09319	gingival:	n/a
21	chr19:43918943-43918993	H1-hESC	embryonic stem cell:	embryo
22	chr19:43918882-43918932	HIPEpiC	eye:	n/a
23	chr19:43912227-43912277	HMEC	breast:	n/a
24	chr19:43922332-43922382	HUVEC	blood vessel:	n/a
25	chr19:43891281-43891331	HEEpiC	esophagus:	n/a
26	chr19:43918974-43919024	BJ	skin:	n/a
27	chr19:43919039-43919089	NB4	blood:	n/a
28	chr19:43892826-43892876	BJ	skin:	n/a
29	chr19:43918465-43918515	SKMC	muscle:	n/a
30	chr19:43922723-43922773	GM12878	blood:	n/a
31	chr19:43918943-43918993	SAEC	small airway:	n/a
32	chr19:43912492-43912542	HNPCEpiC	eye:	n/a
33	chr19:43918465-43918515	HL-60	blood:	n/a
34	chr19:43919028-43919078	HIPEpiC	eye:	n/a
35	chr19:43922332-43922382	PrEC	prostate:	n/a
36	chr19:43891866-43891916	HRCEpiC	kidney:	n/a
37	chr19:43892826-43892876	AG09319	gingival:	n/a
38	chr19:43918882-43918932	ECC-1	luminal epithelium:	n/a
39	chr19:43912492-43912542	GM12878	blood:	n/a
40	chr19:43919003-43919053	SK-N-SH_RA	brain:	n/a
41	chr19:43922332-43922382	AG04450	lung:	fetal
42	chr19:43916594-43916644	AG09319	gingival:	n/a
43	chr19:43916594-43916644	Hepatocyte	liver:	n/a
44	chr19:43892339-43892389	ECC-1	luminal epithelium:	n/a
45	chr19:43918943-43918993	NHBE	bronchial:	n/a
46	chr19:43918408-43918458	SAEC	small airway:	n/a
47	chr19:43918974-43919024	AG09319	gingival:	n/a
48	chr19:43919039-43919089	AG04450	lung:	fetal
49	chr19:43912227-43912277	HRE	kidney:	n/a
50	chr19:43918465-43918515	SAEC	small airway:	n/a

(count:33 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:43809862..43810443-chr19:43929397..43930009,2	MCF-7	breast:
2	chr19:43947823..43950572-chr19:43967998..43969717,2	MCF-7	breast:
3	chr19:43936775..43937531-chr19:44023386..44024282,4	MCF-7	breast:
4	chr19:43950463..43951811-chr19:44023286..44024411,8	MCF-7	breast:
5	chr19:43959047..43960666-chr19:44006896..44009255,2	MCF-7	breast:
6	chr19:43937232..43939100-chr19:44037778..44039902,2	MCF-7	breast:
7	chr19:43949852..43952277-chr19:44156357..44158096,2	K562	blood:
8	chr19:43928435..43931381-chr19:43932773..43935782,3	K562	blood:
9	chr19:43936721..43937673-chr19:43951109..43951816,2	MCF-7	breast:
10	chr19:43950879..43951915-chr19:44023292..44024529,15	K562	blood:
11	chr19:43950972..43953195-chr19:43955258..43957293,2	MCF-7	breast:
12	chr19:43937678..43940228-chr19:44019604..44022571,2	MCF-7	breast:
13	chr19:43928535..43930747-chr19:43966422..43969412,2	MCF-7	breast:
14	chr19:43950829..43952315-chr19:44023277..44024591,13	MCF-7	breast:
15	chr19:43820685..43821690-chr19:43929045..43930443,5	MCF-7	breast:
16	chr19:43936721..43937673-chr19:43951109..43951816,2	MCF-7	breast:
17	chr19:43936817..43937670-chr19:44023393..44024322,3	K562	blood:
18	chr19:43937028..43937653-chr19:43950851..43951764,3	MCF-7	breast:
19	chr19:43937119..43937651-chr19:44098505..44099433,2	MCF-7	breast:
20	chr19:43909136..43910754-chr19:43912460..43914552,2	MCF-7	breast:
21	chr19:43942702..43944453-chr19:44007455..44009598,2	MCF-7	breast:
22	chr19:43956975..43958527-chr19:43968181..43969853,2	MCF-7	breast:
23	chr19:43942400..43947044-chr19:43967250..43970389,5	MCF-7	breast:
24	chr19:43937028..43937653-chr19:43950851..43951764,3	MCF-7	breast:
25	chr19:43928435..43931381-chr19:43932773..43935782,3	K562	blood:
26	chr19:43942729..43944786-chr19:43970636..43972210,2	MCF-7	breast:
27	chr19:43821071..43821590-chr19:43929652..43930334,2	MCF-7	breast:
28	chr19:43950972..43953195-chr19:43955258..43957293,2	MCF-7	breast:
29	chr19:43949660..43952729-chr19:43966089..43969502,3	K562	blood:
30	chr19:43937158..43937719-chr19:44059063..44059904,2	K562	blood:
31	chr19:43951229..43953633-chr19:43981664..43984219,2	MCF-7	breast:
32	chr17:42852520..42853209-chr19:43915333..43915833,2	HCT-116	colon:
33	chr19:43950949..43953195-chr19:44029676..44031859,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC005392.1-1	chr19:43872981-43873122	ENSG00000272396.1
2	lnc-AC005392.1-1	chr19:43872981-43873227	NONHSAT066597
3	lnc-AC005392.1-1	chr19:43872546-43872658	NONHSAT066597
4	lnc-TEX101-2	chr19:43893587-43893979	expReg_chr19_6146_+
5	lnc-TEX101-1	chr19:43895826-43896306	expReg_chr19_6147_+

No data

Variant related genes	Relation type
CD177P1	TF binding region
TEX101	TF binding region
ENSG00000272396	TF binding region
CD177P1	CpG island
TEX101	CpG island
ENSG00000272396	CpG island
ENSG00000124466	chromatin interactions
ENSG00000073670	chromatin interactions
ENSG00000176531	chromatin interactions
ENSG00000131126	chromatin interactions
ENSG00000105755	chromatin interactions

Extended variants
information (count: 3581 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:3581 , 50 per page) page: 1 2 3 4 5 6 7 ... 72

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7257560	chr19:43866823-43866824	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs546272956	chr19:43866852-43866853	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs185660774	chr19:43866853-43866854	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs191498220	chr19:43866896-43866897	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs7257009	chr19:43866906-43866907	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs113972880	chr19:43866951-43866952	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs554358201	chr19:43866952-43866953	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs113119621	chr19:43866997-43866998	Bivalent Enhancer Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs111658539	chr19:43867002-43867003	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs376590966	chr19:43867014-43867015	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs113922157	chr19:43867016-43867017	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs574187894	chr19:43867029-43867030	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs112891342	chr19:43867036-43867037	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs117221321	chr19:43867043-43867044	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs555221284	chr19:43867055-43867056	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs201834817	chr19:43867064-43867065	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs10421323	chr19:43867083-43867084	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs543814024	chr19:43867088-43867089	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs28460459	chr19:43867098-43867099	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs577538503	chr19:43867099-43867100	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs540192203	chr19:43867112-43867113	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs567180290	chr19:43867117-43867118	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs529123147	chr19:43867130-43867131	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs28481973	chr19:43867132-43867133	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs562977798	chr19:43867133-43867134	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs386809564	chr19:43867169-43867170	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs10420998	chr19:43867171-43867172	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs10421007	chr19:43867178-43867179	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs527671907	chr19:43867181-43867182	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs117053000	chr19:43867182-43867183	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs183730346	chr19:43867192-43867193	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs139671640	chr19:43867247-43867248	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs187068927	chr19:43867287-43867288	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs192304328	chr19:43867305-43867306	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs537521307	chr19:43867321-43867322	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs557348573	chr19:43867329-43867330	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs35043884	chr19:43867338-43867339	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs10421824	chr19:43867349-43867350	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs371677470	chr19:43867367-43867368	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs553822170	chr19:43867377-43867378	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs535757669	chr19:43867384-43867385	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs573837846	chr19:43867385-43867386	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs182122873	chr19:43867401-43867402	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs115209644	chr19:43867433-43867434	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs538530830	chr19:43867445-43867446	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs117223916	chr19:43867459-43867460	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs56252620	chr19:43867465-43867466	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs11297631	chr19:43867496-43867497	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs199778681	chr19:43867525-43867526	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs10572342	chr19:43867526-43867527	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21509527	CNVD
Cancer	20164920	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21240255	CNVD
Lung squamous cell carcinoma	22363434	CNVD

Chromatin state (count:714 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43862800-43873200	Weak transcription	Gastric	stomach
2	chr19:43864600-43867600	Strong transcription	Primary neutrophils fromperipheralblood	blood
3	chr19:43864600-43868000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr19:43864600-43868200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr19:43866000-43867000	Bivalent Enhancer	Fetal Stomach	stomach
6	chr19:43866200-43867000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr19:43866200-43867000	Enhancers	Colonic Mucosa	Colon
8	chr19:43866200-43867000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
9	chr19:43866200-43867000	Enhancers	Osteobl	bone
10	chr19:43866200-43867200	Enhancers	NHLF	lung
11	chr19:43866200-43867400	Enhancers	Rectal Mucosa Donor 31	rectum
12	chr19:43866400-43867000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr19:43866400-43867200	Enhancers	Rectal Mucosa Donor 29	rectum
14	chr19:43866400-43868200	Weak transcription	Spleen	Spleen
15	chr19:43866600-43868000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr19:43866800-43868000	Weak transcription	Sigmoid Colon	Sigmoid Colon
17	chr19:43867200-43868200	Weak transcription	Rectal Mucosa Donor 29	rectum
18	chr19:43867400-43870600	Weak transcription	Rectal Mucosa Donor 31	rectum
19	chr19:43867600-43872000	Weak transcription	Primary neutrophils fromperipheralblood	blood
20	chr19:43867800-43868000	Enhancers	Colonic Mucosa	Colon
21	chr19:43868000-43868400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
22	chr19:43868000-43868400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr19:43868000-43868400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
24	chr19:43868200-43868400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr19:43868200-43868400	Enhancers	Rectal Mucosa Donor 29	rectum
26	chr19:43868200-43868400	Enhancers	Sigmoid Colon	Sigmoid Colon
27	chr19:43868200-43868400	Enhancers	Spleen	Spleen
28	chr19:43868200-43868600	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr19:43868400-43868600	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr19:43868400-43871800	Weak transcription	Rectal Mucosa Donor 29	rectum
31	chr19:43868400-43876600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:43870000-43870200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr19:43870600-43871000	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr19:43870600-43871200	Enhancers	Stomach Mucosa	stomach
35	chr19:43871000-43871800	Weak transcription	Rectal Mucosa Donor 31	rectum
36	chr19:43871200-43871600	Weak transcription	Stomach Mucosa	stomach
37	chr19:43871600-43873200	Enhancers	Stomach Mucosa	stomach
38	chr19:43871800-43872000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
39	chr19:43871800-43872000	Enhancers	Rectal Mucosa Donor 29	rectum
40	chr19:43871800-43872000	Enhancers	Rectal Mucosa Donor 31	rectum
41	chr19:43872000-43873000	Weak transcription	Rectal Mucosa Donor 31	rectum
42	chr19:43872000-43873400	Enhancers	Primary neutrophils fromperipheralblood	blood
43	chr19:43873000-43873200	Enhancers	iPS-18 Cell Line	embryonic stem cell
44	chr19:43873000-43873200	Enhancers	Rectal Mucosa Donor 31	rectum
45	chr19:43873200-43874200	Enhancers	Gastric	stomach
46	chr19:43873400-43876600	Weak transcription	Primary neutrophils fromperipheralblood	blood
47	chr19:43873600-43874800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
48	chr19:43874200-43874800	Weak transcription	Gastric	stomach
49	chr19:43874800-43875000	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr19:43874800-43875000	Enhancers	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links